OTE welcomes new editor

Article

Ophthalmology Times Europe founding editor, Fedra Pavlou, is to become Editor-in-Chief of Pharmaceutical Technology Europe, another of Advanstar's publications. Pamela Brook joins the team as editor of OTE, with immediate effect.

Ophthalmology Times Europe founding editor, Fedra Pavlou, is to become Editor-in-Chief of Pharmaceutical Technology Europe, another of Advanstar's publications. Pamela Brook joins the team as editor of OTE, with immediate effect. However, the OTE portfolio will continue to benefit from Fedra's expertise, as she will continue to contribute her valuable knowledge at various times throughout this coming year. Commenting on the changes Fedra said: "It has been a pleasure to be involved in such an exciting and rewarding industry and thank you to all our readers for your input, feedback and kind words since our launch."

Incoming editor, Pamela Brook said: "No reader of OTE can doubt that it is Fedra, and her team's, hard work, commitment and extensive knowledge of the industry that has made Ophthalmology Times Europe the success it is today. We all wish her every success in her new role. In turn, I am extremely pleased to be joining OTE at what promises to be both a changing and, subsequently, challenging time."

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.